Allergy/Asthma News

Infants with bronchiolitis caused by rhinovirus C were more likely to develop recurrent wheeze by age 3 years compared with infants who had bronchiolitis caused by other viruses, according to findings published in JAMA Pediatrics.

Pre-diabetes and diabetes are risk factors for asthma exacerbations in adults with asthma and obesity, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

A Danish cohort study revealed that nearly one-in-four patients with inflammatory bowel disease have another immune mediated inflammatory disease which can impact disease course and increase severity.

A recent study, named AsthmaDIET, found evidence that children with a diet higher in omega-3 fatty acids had fewer asthma symptoms caused by indoor air pollution, whereas children with diets higher in omega-6 fatty acids experienced more severe asthma symptoms.

A unique inflammatory signature among older patients with chronic rhinosinusitis may make them less responsive to steroid treatment, according to findings recently published in the Journal of Allergy and Clinical Immunology.

The size of the peanut skin prick test size increased over time in infants at risk for peanut allergy, according to an abstract presented at the American Academy of Allergy, Asthma and Immunology annual meeting.

Supplementing atopic dermatitis treatment with probiotics does not benefit children, according to research presented at the American Academy of Allergy, Asthma and Immunology annual meeting.

A simulation that used serology to screen children with asthma for mite sensitization saved more than $4 billion over 5 years, according to a poster presented at the American Academy of Allergy, Asthma and Immunology Annual Scientific Meeting.

Automatically flagging new referrals and reserving clinic and challenge appointments for infants allowed for faster scheduling of peanut allergy evaluations than usual, according to a study presented at the American Academy of Allergy, Asthma and Immunology Annual Scientific Meeting.

Takhzyro, a monoclonal antibody, was found to safely reduce monthly attack rates in adolescents with hereditary angioedema, according to research presented at the American Academy of Allergy, Asthma and Immunology annual meeting.